SCHEMBL6601776

SCHEMBL6601776

CC(C)N(OP(OCc1ccc([N+](=O)[O-])cc1)OCc1ccc([N+](=O)[O-])cc1)C(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.49
AKR1C3 P42330 1/20 0.44
HTR2A P28223 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CYP19A1 P11511 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAOB P27338 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.41
KCNH2 Q12809 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
LMNA P02545 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8688056 0.82 IDO1 (0.63) IDO1AKR1C3CA12CA1CA2
SCHEMBL6754023 0.81 IDO1 (0.54) IDO1AKR1C3HTR2ACA12CA1
SCHEMBL6754021 0.81 IDO1 (0.54) IDO1AKR1C3HTR2ACA12CA1
SCHEMBL14247542 0.81 IDO1 (0.50) IDO1AKR1C3HTR2ACA12CA1
SCHEMBL12646388 0.78 IDO1 (0.54) IDO1AKR1C3CA12CA1CA2
SCHEMBL4869141 0.78 TSHR (0.39) IDO1CA1CA2CA9ALDH1A1
SCHEMBL11569397 0.74 IDO1 (0.61) IDO1AKR1C3CA12CA1CA2
SCHEMBL6753829 0.73 KCNH2 (0.49) IDO1LOXL2KCNH2
SCHEMBL17662368 0.73 IDO1 (0.59) IDO1AKR1C3HTR2ACA12CA1
SCHEMBL8688058 0.73 IDO1 (0.59) IDO1AKR1C3CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0924210-B1 2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives WYETH K K (JP) 2004-08-18 EP disclosed
EP-0632039-B1 2-[1-(1,3-Thiazolin-2-yl)azetidin-3-yl]thio-carbapenem derivatives WYETH LEDERLE JAPAN LTD (JP) 2002-01-30 EP disclosed
EP-0924210-A1 2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives LEDERLE (JAPAN), Ltd. (JP) 1999-06-23 EP disclosed
US-5783703-A CARBAPENEM INTERMEDIATES LEDERLE (JAPAN), LTD. (JP) 1998-07-21 US disclosed
US-5679790-A ANTIBIOTICS, BACTERICIDES LEDERLE (JAPAN), LTD. (JP) 1997-10-21 US disclosed
US-5534510-A ORALLY ADMINISTRABLE THIENAMYCIN ANTIBIOTICS; BETA-LACTAMASE INHIBITORS LEDERLE (JAPAN), LTD. (JP) 1996-07-09 US disclosed
EP-0632039-A1 2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives LEDERLE (JAPAN), Ltd. (JP) 1995-01-04 EP disclosed